Literature DB >> 23868335

Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.

Kalkidan Bishu1, Margaret M Redfield.   

Abstract

Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to $53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23868335      PMCID： PMC3870333          DOI： 10.1007/s11897-013-0149-5

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  56 in total

1.  Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.

Authors:  Yasuyuki Kaneko; John S Floras; Kengo Usui; Julie Plante; Ruzena Tkacova; Toshihiko Kubo; Shin-ichi Ando; T Douglas Bradley
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.

Authors:  Erland Erdmann; Marc J Semigran; Markku S Nieminen; Mihai Gheorghiade; Rahul Agrawal; Veselin Mitrovic; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2012-07-09       Impact factor: 29.983

3.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Authors:  John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana R Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas M Severin; Marco Metra
Journal:  Lancet       Date:  2012-11-07       Impact factor: 79.321

4.  Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

Authors:  Marco Metra; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Margaret F Prescott; Christopher Edwards; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas Severin; John R Teerlink
Journal:  J Am Coll Cardiol       Date:  2013-01-15       Impact factor: 24.094

5.  Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization.

Authors:  K Kramer; P Kirkman; D Kitzman; W C Little
Journal:  Am Heart J       Date:  2000-09       Impact factor: 4.749

6.  Acute heart failure: perspectives from a randomized trial and a simultaneous registry.

Authors:  Justin A Ezekowitz; Jia Hu; Diego Delgado; Adrian F Hernandez; Padma Kaul; Rolland Leader; Guy Proulx; Sean Virani; Michel White; Shelley Zieroth; Christopher O'Connor; Cynthia M Westerhout; Paul W Armstrong
Journal:  Circ Heart Fail       Date:  2012-10-02       Impact factor: 8.790

7.  Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.

Authors:  Nazha Hamdani; Kalkidan G Bishu; Marion von Frieling-Salewsky; Margaret M Redfield; Wolfgang A Linke
Journal:  Cardiovasc Res       Date:  2012-12-04       Impact factor: 10.787

8.  Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.

Authors:  Kalkidan Bishu; Anita Deswal; Horng H Chen; Martin M LeWinter; Gregory D Lewis; Marc J Semigran; Barry A Borlaug; Steven McNulty; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Am Heart J       Date:  2012-10-16       Impact factor: 4.749

9.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

Authors:  Bradley A Bart; Steven R Goldsmith; Kerry L Lee; Michael M Givertz; Christopher M O'Connor; David A Bull; Margaret M Redfield; Anita Deswal; Jean L Rouleau; Martin M LeWinter; Elizabeth O Ofili; Lynne W Stevenson; Marc J Semigran; G Michael Felker; Horng H Chen; Adrian F Hernandez; Kevin J Anstrom; Steven E McNulty; Eric J Velazquez; Jenny C Ibarra; Alice M Mascette; Eugene Braunwald
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245

Review 10.  Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.

Authors:  Filippo Brandimarte; Muthiah Vaduganathan; Gian Francesco Mureddu; Giuseppe Cacciatore; Hani N Sabbah; Gregg C Fonarow; Steven R Goldsmith; Javed Butler; Francesco Fedele; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214
View more
  8 in total

1.  Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction.

Authors:  Fernando Friões; Patrícia Lourenço; Olga Laszczynska; Pedro-Bernardo Almeida; João-Tiago Guimarães; James L Januzzi; Ana Azevedo; Paulo Bettencourt
Journal:  Clin Res Cardiol       Date:  2015-01-14       Impact factor: 5.460

2.  Effects of glycemic control on in-hospital mortality among acute heart failure patients with reduced, mid-range, and preserved ejection fraction.

Authors:  Kenichi Matsushita; Kazumasa Harada; Tetsuro Miyazaki; Takamichi Miyamoto; Kiyoshi Iida; Shuzou Tanimoto; Mayuko Yagawa; Makoto Takei; Yuji Nagatomo; Toru Hosoda; Hideaki Yoshino; Takeshi Yamamoto; Ken Nagao; Morimasa Takayama
Journal:  Heart Vessels       Date:  2018-03-14       Impact factor: 2.037

Review 3.  Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.

Authors:  Wengen Chen; Van-Khue Ton; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

4.  Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings.

Authors:  Andrew H Coles; Kimberly Fisher; Chad Darling; Jorge Yarzebski; David D McManus; Joel M Gore; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2014-07-02       Impact factor: 2.778

5.  Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).

Authors:  Siu-Hin Wan; Susanna R Stevens; Barry A Borlaug; Kevin J Anstrom; Anita Deswal; G Michael Felker; Michael M Givertz; Bradley A Bart; W H Wilson Tang; Margaret M Redfield; Horng H Chen
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

6.  Congestive heart failure: experimental model.

Authors:  Antonio Francesco Corno; Xue Cai; Caroline B Jones; Giuseppina Mondani; Mark R Boyett; Jonathan Charles Jarvis; George Hart
Journal:  Front Pediatr       Date:  2013-10-28       Impact factor: 3.418

Review 7.  Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.

Authors:  Van-Khue Ton; Monica Mukherjee; Daniel P Judge
Journal:  Clin Med Insights Cardiol       Date:  2015-01-05

8.  Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study.

Authors:  Anna Schertz; Birgit Herbeck Belnap; Mira-Lynn Chavanon; Frank Edelmann; Rolf Wachter; Christoph Herrmann-Lingen
Journal:  ESC Heart Fail       Date:  2019-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.